Reply to the Letter to Editor by Lacout and colleagues: Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
J Gen Intern Med
.
2021 Aug;36(8):2468-2469.
doi: 10.1007/s11606-021-06722-8.
Epub 2021 Apr 26.
Authors
Manya Prasad
1
,
Arunmozhimaran Elavarasi
2
,
Pramod Garg
3
Affiliations
1
Department of Community Medicine, NDMC Medical College, New Delhi, India.
2
Departments of Neurology, All India Institute of Medical Sciences, New Delhi, India.
3
Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India. pkgarg@aiims.ac.in.
PMID:
33904037
PMCID:
PMC8075020
DOI:
10.1007/s11606-021-06722-8
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents / therapeutic use
COVID-19 Drug Treatment*
Chloroquine
Humans
Hydroxychloroquine*
SARS-CoV-2
Substances
Antiviral Agents
Hydroxychloroquine
Chloroquine